Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
November 18 2021 - 6:04AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO
RULE 13a-16
OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT
OF 1934
For the month of November 2021
Commission file number: 001-38775
ITAMAR MEDICAL LTD.
(Name of registrant)
9 Halamish Street, Caesarea 3088900, Israel
(Address of principal executive office)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F S
Form 40-F ¨
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
EXPLANATORY NOTE
On November 18, 2021, Itamar Medical Ltd. issued
a press release entitled "Itamar Medical Reports Third Quarter 2021 Financial Results", which is attached to this Form 6-K as
Exhibit 99.1.
Exhibits
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
|
ITAMAR MEDICAL LTD.
|
|
|
|
By:
|
/s/ Shy Basson
|
|
Shy Basson
Chief Financial Officer
|
Date: November 18, 2021
Itamar Medical (NASDAQ:ITMR)
Historical Stock Chart
From Aug 2024 to Sep 2024
Itamar Medical (NASDAQ:ITMR)
Historical Stock Chart
From Sep 2023 to Sep 2024